|
1
|
Bielack SS, Kempf-Bielack B, Delling G, et
al: Prognostic factors in high-grade osteosarcoma of the
extremities or trunk: an analysis of 1,702 patients treated on
Neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin
Oncol. 20:776–790. 2002. View Article : Google Scholar
|
|
2
|
Meyers PA and Gorlick R: Osteosarcoma.
Pediatr Clin North Am. 44:973–989. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dai X, Ma W, He X and Jha RK: Review of
therapeutic strategies for osteosarcoma, chondrosarcoma, and
Ewing’s sarcoma. Med Sci Monit. 17:RA177–RHA190. 2011.
|
|
4
|
Watson RL, Spalding AC, Zielske SP, et al:
GSK3beta and beta-catenin modulate radiation cytotoxicity in
pancreatic cancer. Neoplasia. 12:357–365. 2010.PubMed/NCBI
|
|
5
|
Shi X, Hong T, Walter KL, et al: ING2 PHD
domain links histone H3 lysine 4 methylation to active gene
repression. Nature. 442:96–99. 2006.PubMed/NCBI
|
|
6
|
Nagashima M, Shiseki M, Miura K, et al:
DNA damage-inducible gene p33ING2 negatively regulates cell
proliferation through acetylation of p53. Proc Natl Acad Sci USA.
98:9671–9676. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagashima M, Shiseki M, Pedeux RM, et al:
A novel PHD-finger motif protein, p47ING3, modulates p53-mediated
transcription, cell cycle control and apoptosis. Oncogene.
22:343–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shiseki M, Nagashima M, Pedeux RM, et al:
p29ING4 and p28ING5 bind to p53 and p300 and enhance p53 activity.
Cancer Res. 63:2373–2378. 2003.PubMed/NCBI
|
|
9
|
Guérillon C, Larrieu D and Pedeux R: ING1
and ING2: multifaceted tumor suppressor genes. Cell Mol Life Sci.
70:3753–3772. 2013.PubMed/NCBI
|
|
10
|
Borkosky SS, Gunduz M, Nagatsuka H, et al:
Frequent deletion of ING2 locus at 4q35.1 associates with advanced
tumor stage in head and neck squamous cell carcinoma. J Cancer Res
Clin Oncol. 135:703–713. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang HK, Pan K, Wang H, et al: Decreased
expression of ING2 gene and its clinicopathological significance in
hepatocellular carcinoma. Cancer Lett. 261:183–192. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kumamoto K, Fujita K, Kurotani R, et al:
ING2 is upregulated in colon cancer and increases invasion by
enhanced MMP13 expression. Int J Cancer. 125:1306–1315. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kyte J and Doolittle RF: A simple method
for displaying the hydrophobic character of a protein. J Mol Biol.
157:105–132. 1982. View Article : Google Scholar
|
|
14
|
Hopp TP and Woods KR: Prediction of
protein antigenic determinants from amino acid sequences. Proc Natl
Acad Sci USA. 78:3824–3828. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vihinen M, Torkkila E and Riikonen P:
Accuracy of protein flexibility predictions. Proteins. 19:141–149.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Trier NH, Hansen PR and Houen G:
Production and characterization of peptide antibodies. Methods.
56:136–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dimri GP, Lee X, Basile G, et al: A
biomarker that identifies senescent human cells in culture and in
aging skin in vivo. Proc Natl Acad Sci USA. 92:9363–9367. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jackson DA and Pombo A: Replicon clusters
are stable units of chromosome structure: evidence that nuclear
organization contributes to the efficient activation and
propagation of S phase in human cells. J Cell Biol. 140:1285–1295.
1998. View Article : Google Scholar
|
|
19
|
Walzak AA, Veldhoen N, Feng X, Riabowol K
and Helbing CC: Expression profiles of mRNA transcript variants
encoding the human inhibitor of growth tumor suppressor gene family
in normal and neoplastic tissues. Exp Cell Res. 314:273–285. 2008.
View Article : Google Scholar
|
|
20
|
Ythier D, Brambilla E, Binet R, et al:
Expression of candidate tumor suppressor gene ING2 is lost in
non-small cell lung carcinoma. Lung Cancer. 69:180–186. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu F, Dai DL, Martinka M, Ho V and Li G:
Nuclear ING2 expression is reduced in human cutaneous melanomas. Br
J Cancer. 95:80–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pedeux R, Sengupta S, Shen JC, et al: ING2
regulates the onset of replicative senescence by induction of
p300-dependent p53 acetylation. Mol Cell Biol. 25:6639–6648. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gozani O, Karuman P, Jones DR, et al: The
PHD finger of the chromatin-associated protein ING2 functions as a
nuclear phosphoinositide receptor. Cell. 114:99–111. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pena PV, Davrazou F, Shi X, et al:
Molecular mechanism of histone H3K4me3 recognition by plant
homeodomain of ING2. Nature. 442:100–103. 2006.PubMed/NCBI
|
